DENTSPLY VP stock withheld for tax on awards

DENTSPLY SIRONA Inc. reported that officer Kevin Czerney, its VP and Chief Accounting Officer, had company shares withheld to cover tax obligations from vesting equity awards.

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. reported that officer Kevin Czerney, its VP and Chief Accounting Officer, had company shares withheld to cover tax obligations from vesting equity awards. On March 3, 2026, tax-withholding dispositions of 527 and 1,197 shares of common stock occurred at prices of $13.30 per share. On March 4, 2026, an additional 328 shares were withheld at $13.44 per share. These transactions relate to the vesting of performance-based and time-based restricted stock units and associated dividend equivalent units and are not open-market sales.

Insider Trade Summary

Exercise Price or Tax Liability: 2,052 shares

Exercise Price or Tax Liability 3 txns

Insider Czerney Kevin

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	328	$13.44	$4K
Exercise Price or Tax Liability	Common Stock	527	$13.30	$7K
Exercise Price or Tax Liability	Common Stock	1,197	$13.30	$16K

Holdings After Transaction: Common Stock — 27,578.908 shares (Direct)

Footnotes (2)

1. F1. Shares withheld to cover taxes related to the vesting of the reporting person's Performance-Based Restricted Stock Units and dividend equivalent units previously reported in Table I.
2. F2. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DENTSPLY SIRONA (XRAY) report for Kevin Czerney?

DENTSPLY SIRONA reported that VP and Chief Accounting Officer Kevin Czerney had common shares withheld to satisfy taxes from vesting equity awards. These were tax-withholding dispositions tied to restricted stock unit and performance-based restricted stock unit vesting, not open-market stock sales.

How many DENTSPLY SIRONA (XRAY) shares were used for tax withholding?

The filing shows three tax-withholding transactions: 527 and 1,197 common shares on March 3, 2026, and 328 shares on March 4, 2026. Each block was withheld to cover tax obligations when previously granted equity awards and related dividend equivalents vested.

At what prices were the DENTSPLY SIRONA (XRAY) tax-withholding shares valued?

The shares withheld on March 3, 2026 were valued at a price of $13.30 per share, and the March 4, 2026 withholding used a price of $13.44 per share. These per-share values are used solely to determine the number of shares needed to satisfy tax liabilities.

Were the DENTSPLY SIRONA (XRAY) insider transactions open-market sales?

No, the transactions were not open-market sales. The Form 4 describes them as code F tax-withholding dispositions, where shares are delivered to cover exercise price or tax liabilities upon vesting of restricted stock units and performance-based restricted stock units, including dividend equivalent units.

What types of awards caused the DENTSPLY SIRONA (XRAY) share withholdings?

The share withholdings were triggered by the vesting of performance-based restricted stock units, regular restricted stock units, and associated dividend equivalent units. All of these awards had been previously reported, and the shares were withheld to cover related tax obligations when those awards vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 07:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Czerney Kevin

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		F		527(1)	D	$13.3	29,103.908	D
Common Stock	03/03/2026		F		1,197(2)	D	$13.3	27,906.908	D
Common Stock	03/04/2026		F		328(2)	D	$13.44	27,578.908	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld to cover taxes related to the vesting of the reporting person's Performance-Based Restricted Stock Units and dividend equivalent units previously reported in Table I.

2. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Kevin Czerney	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.